PLX
Protalix BioTherapeutics (DE) (PLX)
$06
About Protalix BioTherapeutics (DE) (PLX)
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Details
Daily high
$1.08
Daily low
$1.04
Price at open
$1.06
52 Week High
$1.90
52 Week Low
$0.82
Market cap
78.0M
Dividend yield
0.00%
Volume
85
Avg. volume
131,320
P/E ratio
-4.84
Protalix BioTherapeutics (DE) News
Details
Daily high
$1.08
Daily low
$1.04
Price at open
$1.06
52 Week High
$1.90
52 Week Low
$0.82
Market cap
78.0M
Dividend yield
0.00%
Volume
85
Avg. volume
131,320
P/E ratio
-4.84